Ryan Crowe
Vice President, Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-08
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2026 Earnings Call2026-04-29
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-01-30
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-10-28
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-01
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-04-29
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-10-31
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-01
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-05-02
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-10-05
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-08-03
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-04-10
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-02-03
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-03
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-08-03
Regeneron Pharmaceuticals, Inc. (REGN)
-
Regeneron Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-05-04
Regeneron Pharmaceuticals, Inc. (REGN)